Lactobacillus plantarum King23 for improving and relieving cat urinary tract infection and application thereof

By using the King23 bacteria agent of Plantababacterium lactobacillus, the problems of high recurrence rate of urinary tract infection and resistance to antibiotic treatment were solved, significantly inhibiting urinary tract infection pathogens, improving treatment effect and reducing recurrence rate, and improving cat urinary system health.

CN118530912BActive Publication Date: 2024-11-01MINSHENG WEIMAN (SHANDONG) ANIMAL HEALTH TECHNOLOGY CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410954559.1
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-07-17
Publication Date
2024-11-01
Estimated Expiration
2044-07-17

AI Technical Summary

Technical Problem

The recurrence rate of urinary tract infection in cats is high, existing antibiotic treatment may lead to drug resistance, and the prevention and treatment effect of existing probiotic preparations on cats' urinary tract infection is not clearly determined, and effective application of Lactobacillus plantarum is lacking.

Method used

King23 (classified as Lactiplantibacillus plantarum, preservation number CGMCC No. 30180), is used to mix it with isomaltose oligosaccharides to inhibit urinary tract infection pathogens and promote urinary tract System health.

Benefits of technology

Significantly inhibit pathogens of urinary tract infection in cats, improve treatment efficiency, reduce recurrence rates, improve symptoms such as frequent urination, pain in urine, hematuria, difficulty in urination and loss of appetite, and improve the health of cats' urinary system.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure SMS_1
    Figure SMS_1
  • Figure SMS_2
    Figure SMS_2
  • Figure SMS_3
    Figure SMS_3
Patent Text Reader

Abstract

The present invention provides a plant lactobacillus King23 for improving and relieving cat urinary tract infection and its application, belonging to the field of microbial technology. The plant lactobacillus King23 is deposited with CGMCC No.30180 and is classified as plant lactobacillus Lactiplantibacillus plantarum , the deposit date is March 28, 2024. The plant lactobacillus King23 of the present invention can inhibit the pathogens of cat urinary tract infection; the plant lactobacillus King23 of the present invention can help cats with urinary tract infection to recover their mental state, relieve the loss of appetite caused by the disease, and improve symptoms such as frequent urination, dysuria, hematuria, dysuria, turbid urine with odor, etc.; the plant lactobacillus King23 of the present invention can significantly improve the treatment efficiency of cat urinary tract infection and reduce the recurrence rate.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to Lactobacillus plantarum King23 for improving and alleviating cat urinary tract infection and application thereof, belonging to the technical field of microorganisms. Background Art

[0002] With the improvement of people's economic level and the increase of pressure of modern life, keeping pets has become an indispensable part of residents' lives. At present, most pets are cats and dogs. As the proportion of pets keeps increasing, the phenomenon of pets getting sick due to unscientific pet owners' keeping methods is becoming more and more prominent. For example, the proportion of feline lower urinary tract disease (FLUTD) has increased significantly, and the disease is easily ignored during the diagnosis and treatment process, and sometimes even misdiagnosed due to clinical diagnosis and treatment errors. Feline lower urinary tract disease, also known as feline urinary system syndrome (FUS), is a comprehensive description of the symptoms of one or more diseases in the urinary system of cats. The clinical symptoms are mainly manifested as lack of energy, frequent urination, dysuria, urinary pain, blood in urine, licking the anus and genitals, abnormal urination behavior, vomiting, decreased appetite, etc. Clinically, feline lower urinary tract disease is divided into obstructive and non-obstructive according to whether the cat urinates smoothly. The treatment methods mainly adopt conservative treatment methods and surgical treatment methods. Conservative treatment is for cases without obstruction, such as cystitis, urethritis and urinary tract infection. Surgical treatment is for cases with urethral obstruction or partial urethral obstruction, such as bladder stones and urethral stones. Conservative treatment mainly takes the form of catheterization, antibiotic treatment, improved feeding management and feeding prescription food to acidify urine. Surgical treatment uses different surgical methods according to different sites of the disease, such as cystotomy, urethrotomy and urethrostomy. Because the urethra of male cats is longer and narrower than that of female cats, lower urinary tract inflammation or urinary tract obstruction is more common in male cats.

[0003] Urinary tract infection (UTI) is one of the important types of diseases in FLUTD. Urinary tract infection in cats refers to inflammatory diseases of the urinary tract caused by bacterial infection, including pyelonephritis, cystitis and urethritis. Urinary tract bacterial infection will increase the concentration of ammonium ions in urine, promote the precipitation of mineral salts to form crystals, and thus form urethral stones. Urinary tract infection and urinary system syndrome are often causal. If the pH of urine increases or becomes alkaline for some reason, it will be conducive to the growth of bacteria. At the same time, the growth of bacteria will also increase the pH of urine, which is conducive to the formation of crystals and cause urinary syndrome. Through the analysis of pathogens in urine samples of cats with urinary tract infections, it was found that Escherichia coli was the most common pathogen causing feline urinary tract infections, followed by Staphylococcus aureus (Defauw et al. Risk Factors and Clinical Presentation of Cats with Feline Idiopathic Cystitis. Journal of Feline Medicine and Surgery, 2011, 13(12): 967-975; Nururrozi et al. Evaluation of lower urinary tract disease in the Yogyakarta cat population, Indonesia. VetWorld, 2020 Jun, 13(6): 1182-1186; Eggertsdóttir et al. Bacteriuria in cats with feline lower urinary tract disease: A clinical study of 134 cases in Norway. Journal of Feline Medicine and Surgery, 2007: 9(6): 458-465.).

[0004] Urinary tract infection has a high recurrence rate and requires long-term use of antibiotics. Long-term use of antibiotics for anti-infection treatment may lead to microbial resistance and decreased antibacterial effect. Although the cure rate of the disease is high, pets will still suffer from pain for a long time. Non-antibiotic preparations have been proven to benefit patients with urinary tract infections. Studies have found that Lactobacillus, Bifidobacterium, and Lactobacillus reuteri have no significant advantages in preventing urinary tract infections (Tian Chao, et al. Systematic evaluation and meta-analysis of the effect of probiotics in preventing urinary tract infections in children [J]. Journal of Pediatric Pharmacy, 2020, 26(05): 16-20.). Combining glutamine with probiotics (Bifidobacterium triple live bacteria powder) can effectively improve the nutritional status and immune function of patients with sepsis caused by urinary tract infection, and significantly improve their prognosis (Zhang Danhong. Effect of early enteral nutrition therapy with glutamine combined with probiotics on the prognosis of sepsis caused by urinary tract infection [J]. Modern Diagnosis and Treatment, 2021, 32(19): 3071-3073.). However, there is no clear conclusion on whether probiotic preparations alone are effective in preventing and treating feline urinary tract infections. There are no reports in the prior art on the use of Lactobacillus plantarum to improve or relieve feline urinary tract infections. Summary of the invention

[0005] In view of the shortcomings of the prior art, the present invention provides a Lactobacillus plantarum King23 for improving and alleviating cat urinary tract infection and its application, to achieve the following invention objectives: it can improve and alleviate cat urinary tract infection, protect the health of the urinary system, inhibit the pathogens of cat urinary tract infection, improve the treatment efficiency of cat urinary tract infection, and reduce the recurrence rate.

[0006] In order to solve the above technical problems, the present invention adopts the following technical solutions:

[0007] A Lactobacillus plantarum King23 for improving and relieving cat urinary tract infection, wherein the Lactobacillus plantarum King23 has a preservation number of CGMCC No.30180 and is classified as Lactobacillus plantarum Lactiplantibacillus plantarum , the preservation date is March 28, 2024.

[0008] The bacterial agent is prepared using the Lactobacillus plantarum King23.

[0009] In the bacterial agent, the number of bacteria is 4.8-5.2×10 9 cfu / g.

[0010] The preparation method of the bacterial agent comprises the following steps: activating and culturing plant lactobacillus King23 to obtain bacterial liquid, collecting bacterial bodies, resuspending the bacterial bodies in reconstituted skim milk to obtain bacterial suspension, freeze-drying the bacterial powder, and mixing the powder with isomaltooligosaccharide to prepare the bacterial agent.

[0011] The application of the Lactobacillus plantarum King23 in preparing a product for improving and alleviating urinary tract infection in cats.

[0012] The plant lactobacillus King23 is classified and named as plant lactobacillus Lactiplantibacillus plants , Depository: General Microbiology Center, China Culture Collection Administration, Deposit date: March 28, 2024, Deposit address: No. 3, Yard No. 1, Beichen West Road, Chaoyang District, Beijing, Postal Code: 100101, Deposit number: CGMCCNo.30180.

[0013] Compared with the prior art, the present invention achieves the following beneficial effects:

[0014] The Lactobacillus plantarum King23 of the present invention can inhibit pathogenic bacteria of cat urinary tract infection and promote the health of the cat's urinary system.

[0015] The Lactobacillus plantarum King23 of the present invention can help cats suffering from urinary tract infection to recover their mental state, relieve the loss of appetite caused by the disease, and improve symptoms such as frequent urination, dysuria, hematuria, dysuria, turbid urine with odor, etc.

[0016] The Lactobacillus plantarum King23 of the present invention can significantly improve the therapeutic efficacy of feline urinary tract infection and reduce the recurrence rate. DETAILED DESCRIPTION

[0017] The preparation method of MRS plate culture medium is as follows: 10g of peptone, 5g of beef powder, 5g of sodium acetate trihydrate, 2g of potassium hydrogen phosphate heptahydrate, 1mL of Tween 80, 0.05g of manganese sulfate tetrahydrate, 2g of triammonium citrate, 20g of glucose, 0.2g of magnesium sulfate heptahydrate, and 15g of agar, dissolve with distilled water, and make up to 1L; mix the above raw materials, adjust the pH naturally, stir evenly, sterilize at 121°C and 0.1MPa for 20min, pour the sterilized culture medium into a plate, let it cool and set aside.

[0018] The preparation method of MRS liquid culture medium is as follows: 10g of peptone, 5g of beef powder, 5g of sodium acetate trihydrate, 2g of potassium hydrogen phosphate heptahydrate, 1mL of Tween 80, 0.05g of manganese sulfate tetrahydrate, 2g of triammonium citrate, 20g of glucose, and 0.2g of magnesium sulfate heptahydrate are dissolved in distilled water and the volume is adjusted to 1L; after mixing the above raw materials, the pH is adjusted to 6.8, and after stirring evenly, sterilized at 121°C and 0.1MPa for 20min.

[0019] The preparation method of LB agar medium is as follows: weigh 40.0 g of LB nutrient agar and add it to 1 L of distilled water, heat and boil until completely dissolved, sterilize it at 121°C under high pressure for 15 min, and then cool it in a clean bench. When the liquid temperature drops to 50-60°C, pour it into a bacterial culture dish to solidify.

[0020] LB liquid culture medium: weigh 25.0 g of LB broth powder and add it to 1 L of distilled water, heat and boil until completely dissolved, and sterilize it by high pressure at 121°C for 15 min.

[0021] Defibrinated sheep blood agar medium: Weigh 6.6 g of nutrient agar, dissolve in 200 mL of distilled water, sterilize at 121°C for 15 min, cool in a clean bench, and when the liquid temperature drops to 50-60°C, add 8 mL of defibrinated sheep blood and mix well, then pour into a bacterial culture dish to coagulate.

[0022] SS agar medium: weigh 60.0g SS agar into 1L distilled water, heat and boil until completely dissolved, cool to about 55℃, pour into a plate for later use.

[0023] Eosin-methylene blue culture medium: weigh 37.5g of eosin-methylene blue agar into 1L of distilled water, heat and boil until completely dissolved, sterilize at 121℃ for 15min, cool to about 55℃, pour into a plate for later use.

[0024] The above-mentioned LB nutrient agar, LB broth, nutrient agar, SS agar, and eosin-methylene blue agar were all purchased from Beijing Luqiao Technology Co., Ltd.

[0025] Example 1 Isolation and identification of bacterial species

[0026] 1. Strain screening and purification

[0027] (1) Strain source: healthy cat intestines, collected in Yanzhou City, Jining City, Shandong Province on May 23, 2021.

[0028] (2) Sample preparation:

[0029] ① Place 10 mL of sterilized saline (0.85%) in a sterile conical flask, then add 1 g of the healthy cat feces from step (1), shake, and set aside;

[0030] ② Dilute the solution in step ① to prepare samples with different concentration gradients, which are 10 -1 , 10 -2 , 10 -3 , 10 -4 , 10 -5 , 10 -6 , 10 -7 , numbered 1#, 2#, 3#, 4#, 5#, 6#, and 7#, for use.

[0031] (3) Cultivation of strains: Take 100 μL of solution 1#, 2#, 3#, 4#, 5#, 6#, and 7#, respectively, and spread it on MRS plate culture medium using a spreader, and culture at 37°C under anaerobic conditions for 48 h.

[0032] (4) Isolation and purification: Based on the characteristics of colony diameter of 1-2 mm, round colonies, neat edges, and slightly white color with a bulge in the middle, single colonies were picked and streaked on MRS plate culture medium in three zones. After streaking, the plate was cultured at 37°C under anaerobic conditions for 48 h. The above operation was repeated for a total of three times to purify the pure strain, which was then added to a glycerol tube and stored at -80°C.

[0033] 2. Identification

[0034] The single colony obtained after separation and purification was sent for identification. The identification unit was China Industrial Microbiological Culture Collection Management Center. The detection method was FMIC-QO01-001-2015 Microbiological Detection Bacterial Multiphase Identification Detection Method. The identification result was: the strain was Lactobacillus plantarum Lactiplantibacillus plantarum .

[0035] The nucleotide sequence of 16S rDNA of the strain is shown as SEQ ID NO.1 in the sequence listing.

[0036] The identified strain was named Lactobacillus plantarum King23 and sent to the General Microbiology Center of China Microbiological Culture Collection Administration for preservation. The preservation information is as follows:

[0037] Lactobacillus plantarum King23, classified as Lactobacillus plantarum Lactiplantibacillus plants , Deposit date: March 28, 2024, Deposit address: No. 3, Yard 1, Beichen West Road, Chaoyang District, Beijing, Postal Code: 100101, Deposit number: CGMCC No.30180.

[0038] Example 2 Preparation of Lactobacillus plantarum King23 bacterial agent

[0039] (1) Take the preserved Lactobacillus plantarum King23 and activate it on MRS plate culture medium, pick a single colony and transfer it to 100 mL MRS liquid culture medium, culture it at 37°C for 12 h to prepare seed liquid, then inoculate it into MRS liquid culture medium at a rate of 1% (v / v), and then culture it at 37°C for 24 h to obtain bacterial liquid;

[0040] (2) After centrifuging the bacterial solution, the cells were collected, washed with sterile saline, and resuspended in 15% (w / w) reconstituted skim milk to obtain a concentration of 2.0 × 10 10cfu / mL of bacterial suspension, freeze-drying the bacterial suspension to obtain bacterial powder;

[0041] (3) The bacterial powder was mixed with isomaltooligosaccharide to prepare Lactobacillus plantarum King 23 bacterial agent. Isomaltooligosaccharide was purchased from Baolingbao Biotechnology Co., Ltd.

[0042] In this embodiment, the number of bacteria in the prepared Lactobacillus plantarum King23 inoculum is 5×10 9 cfu / g.

[0043] Example 3 Experiment on the inhibition of pathogenic bacteria of cat urinary tract infection by Lactobacillus plantarum King23

[0044] 1. Isolation and screening of pathogens

[0045] (1) Urine sample collection: We cooperated with a pet hospital in Shandong Province to collect three cat cases diagnosed with urinary tract infection. After obtaining the consent of the pet owners, we collected three bacteriuria samples for separation and identification.

[0046] (2) Pathogen culture and identification:

[0047] The three urine samples were shaken evenly and diluted with sterile saline to a concentration gradient of 10 -2 For the samples, each diluted sample was inoculated into SS agar medium and eosin-methylene blue medium respectively, and cultured at 37°C for 24 hours to observe the bacterial growth status. The colonies that were milky white on SS agar medium and black with a metallic luster on eosin-methylene blue medium and met the growth characteristics of Escherichia coli were Gram-stained. The bacteria with negative short rods in the Gram staining results were streaked into LB agar medium, cultured at 37°C for 24 hours, and then a single colony was picked and the streaking operation was repeated twice. Three strains that met the characteristics of Escherichia coli colonies were screened and labeled as Escherichia coli E1, Escherichia coli E2, and Escherichia coli E3;

[0048] Preliminary identification was performed based on the morphology of Staphylococcus aureus on LB agar medium and defiberized sheep blood agar plates. Staphylococcus aureus is a round colony on LB agar medium, with a smooth, moist and raised surface, and a golden or lemon yellow color. On the blood agar plate, the colonies are larger, with a diameter of up to 1-2 mm. Some strains have a hemolytic ring around their growth on the blood agar plate. The specific identification method is: take another 10 concentration gradient -2Urine samples were inoculated into the above two culture media respectively. After culturing at 37°C for 24 hours, the characteristics of the colonies were observed and the colonies that met the conditions were selected for Gram staining. Gram-positive colonies with round or oval colonies irregularly arranged in grape clusters (some exist individually) were streaked into LB agar medium. After culturing at 37°C for 24 hours, single colonies were picked and the streaking operation was repeated twice. Three strains that met the colony characteristics of Staphylococcus aureus were screened and labeled as Staphylococcus aureus S1, Staphylococcus aureus S2, and Staphylococcus aureus S3.

[0049] (3) Virus challenge test

[0050] The three strains of Escherichia coli and three strains of Staphylococcus aureus isolated from the three bacteriuria samples were inoculated into LB liquid culture medium and cultured at 37°C for 8 h. The concentration of the bacterial solution was determined by colony counting and diluted to 1×10 8 CFU / mL, and 6 isolates were obtained. 56 BALB / c mice were randomly divided into 7 groups, 8 mice in each group. The mice in the experimental group were intraperitoneally injected with 1×10 8 The mice in the control group were intraperitoneally injected with 0.5 mL of the isolated strain liquid with CFU / mL, and the mice in the control group were intraperitoneally injected with 0.5 mL of LB liquid medium. The mice in each group were kept in isolation, and the clinical symptoms of the mice were observed within 5 days after the infection. All dead mice were dissected in time to observe the pathological changes of the internal organs, and the liver tissue was inoculated into the Escherichia coli chromogenic culture medium.

[0051] The results are shown in Table 1. During the observation period, there were no abnormalities in the control group mice, and different numbers of mice in the experimental group died. The liver tissue samples of the dead mice in the experimental group were inoculated into eosin-methylene blue medium and LB agar medium respectively. The culture results showed that the E1, E2, and E3 groups all obtained uniform and consistent high-purity black colonies with metallic luster, and the S1, S2, and S3 groups all isolated Staphylococcus aureus. Among them, Escherichia coli E2 and Staphylococcus aureus S1 had the highest lethality, and they were used for the next test.

[0052] Table 1 Challenge test of pathogenic bacteria isolates

[0053]

[0054] (4) Pathogenicity test

[0055] After activating and culturing the test pathogens Escherichia coli E2 and Staphylococcus aureus S1, the concentration of the pathogen solution was adjusted to 1×10 4CFU / mL, for future use. Six Chinese rural cats were randomly divided into two groups, E2 and S1, with three cats in each group. They were gavaged with 1 mL / kg body weight, once every 24 hours, for two consecutive times. The cats were observed for abnormal urination behaviors such as frequent urination, dysuria, turbid urine, hematuria, and foul-smelling urine. If the above symptoms occurred, the symptoms were recorded, urine bacterial culture was performed, and effective treatment was carried out in a timely manner.

[0056] The symptoms after oral administration are shown in Table 2. All cats showed abnormal urination behavior, and the urine bacterial count results were all ≥10³CFU / mL, confirming urinary tract infection; this indicates that Escherichia coli E2 and Staphylococcus aureus S1 are both pathogenic bacteria of cat urinary tract infection.

[0057] Table 2 Symptoms of cats

[0058]

[0059] 2. Test on inhibiting pathogens of cat urinary tract infection

[0060] The Lactobacillus plantarum King23, Lactobacillus plantarum JYLP-375 (preservation number: CGMCC No. 18039), and Lactobacillus plantarum JYLP-171 (preservation number: CGMCC No. 18037) preserved in the laboratory were prepared into bacterial solution according to the method of step (1) in Example 2, and the bacterial solution was diluted to a concentration of 1×10 8 CFU / mL. After activating and culturing the test pathogens Escherichia coli E2 and Staphylococcus aureus S1, the concentration of the pathogen solution was adjusted to 1×10 8 CFU / mL. Pipette 1mL of pathogenic bacteria solution into 500mL of 40℃ LB agar medium, mix thoroughly and dispense 20mL per dish into the culture dish. After the culture medium cools and solidifies, punch holes with a 6mm diameter puncher. Pipette 40μL of diluted Lactobacillus plantarum solution into the agar plate wells, culture at 37℃ for 24h, and measure the diameter of the inhibition zone around the wells with a vernier caliper (accuracy 0.01mm). The experiment was repeated 3 times, and MRS liquid culture medium was set as the negative control, and penicillin-streptomycin double antibody (penicillin 10000U / mL, streptomycin 10000 µg / mL) was set as the positive control.

[0061] As shown in Table 3, Lactobacillus plantarum King23 has a stronger inhibitory effect on the two pathogens with strong lethality than the other two Lactobacillus plantarum strains, and the diameter of the inhibition zone is significantly increased.

[0062] Table 3 Evaluation of antibacterial activity

[0063]

[0064] Example 4 Effect of Lactobacillus plantarum King23 on improving feline urinary tract infection and related complications

[0065] Together with a pet hospital in Shandong Province, 20 sick cats diagnosed with single urinary tract infection were recruited and randomly divided into a control group and an observation group, with 10 cats in each group. The control group was subcutaneously injected with amoxicillin and clavulanate potassium injection (Pfizer International Trade (Shanghai) Co., Ltd.) at a body weight dose of 0.05 mL / kg, once a day for 5 consecutive days. The observation group was fed 1.5 g of Lactobacillus plantarum King23 prepared in Example 2 2 hours after the daily injection of amoxicillin and clavulanate potassium injection, and fed continuously for 5 days.

[0066] On the 0th, 3rd and 5th days of the experiment, the cats' body temperature, respiration, pulse, mental state, food intake and urinary tract infection symptoms were observed by practicing veterinarians according to the method described in the Veterinary Clinical Diagnostics (the scoring criteria for clinical symptom observation items are shown in Table 4), and urine samples were collected by bladder puncture for urine bacterial culture examination (each urine sample was measured 3 times and the average value was taken, and the urine bacterial content was ≥10 3 CFU / mL is bacterial urine, and urinary tract infection is diagnosed). The results are analyzed for effectiveness. After the 5-day trial period, the pet owner will continue to observe the cat. If the cat has frequent urination, urgency, hematuria, pain, turbid urine, abnormal color, pungent odor, etc. within 1 month, it will be taken to the pet hospital for diagnosis to determine whether the urinary tract infection has recurred.

[0067] Effectiveness determination criteria: ① Significantly effective: clinical symptom score ≤ 1, urine test, bacteriology and other indicators are healthy. ② Effective: 1 < clinical symptom score ≤ 2, urine test, bacteriology and other indicators are healthy or slightly abnormal. ③ Ineffective: clinical symptom score > 2, urine test, bacteriology and other indicators are beyond the healthy range.

[0068] Effective rate = (markedly effective + effective) / total number of cases × 100%; recurrence rate = number of recurrent cases / total number of cases × 100%.

[0069] Table 4 Clinical symptom observation items and scoring criteria

[0070]

[0071] Results: The results of clinical physiological indicators are shown in Table 5. During the entire treatment period, the average values ​​of body temperature, respiratory rate, and pulse rate of all cats were within the normal range, and there were no significant differences in the data between different groups at the same time point. The combined treatment with Lactobacillus plantarum King23 did not cause abnormal clinical physiological indicators of cats.

[0072] According to the clinical symptom score results (Table 6), the comprehensive scores of the control group and the observation group in spirit, feeding, and urination were close before the experiment. On the third day of treatment, the symptom score of the observation group was significantly lower than that of the control group. On the fifth day, the score of the observation group was still lower than that of the control group. This shows that the observation group has significantly improved the spirit, feeding, and urination of cats with urinary tract infection. Lactobacillus plantarum King23 can help restore the mental state, relieve the loss of appetite caused by the disease, and improve symptoms such as frequent urination, dysuria, hematuria, dysuria, and turbid urine with odor.

[0073] By comparing the bacterial content in urine before and after treatment (Table 7), it was found that the urine bacterial content in the control group and the observation group returned to the normal range on the 5th day, but the difference between the two was large, indicating that Lactobacillus plantarum King23 has a good clearing effect on urinary tract infection pathogens.

[0074] And according to the statistical results of the effective rate (Table 8) and the recurrence rate (Table 9), the treatment effective rate of the observation group was higher than that of the control group, and the recurrence rate of the observation group was also lower than that of the control group, indicating that Lactobacillus plantarum King23 can improve the treatment effectiveness of feline urinary tract infection and reduce the recurrence rate.

[0075] Table 5 Body temperature, respiration and pulse of sick cats before and after the experiment

[0076]

[0077] Table 6 Clinical symptom scoring results

[0078]

[0079] Table 7 Comparison of urine bacterial count (unit: CFU / mL)

[0080]

[0081] Table 8 Comparison of effective rates

[0082]

[0083] Table 9 Comparison of recurrence rate

[0084] .

Claims

1. A Lactobacillus plantarum King23 for improving and relieving urinary tract infection in cats, characterized in that: The Lactobacillus plantarum King23 has a deposit number of CGMCC No.30180 and is classified as Lactobacillus plantarum Lactiplantibacillus plantarum , the preservation date is March 28, 2024.

2. A bacterial agent prepared using the plant lactobacillus King23 according to claim 1.

3. The bacterial agent according to claim 2, characterized in that: In the bacterial agent, the number of bacteria is 4.8-5.2×10 9 cfu / g.

4. The bacterial agent according to claim 2, characterized in that: The preparation method of the bacterial agent comprises the following steps: activating and culturing plant lactobacillus King23 to obtain bacterial liquid, collecting bacterial bodies, resuspending the bacterial bodies in reconstituted skim milk to obtain bacterial suspension, freeze-drying the bacterial powder, and mixing the powder with isomaltooligosaccharide to prepare the bacterial agent.

5. Use of the Lactobacillus plantarum King23 according to claim 1 in the preparation of a medicament for improving and alleviating feline urinary tract infection.